Market watchers may believe the weak GMP reflects concerns over the IPO’s rich valuation rather than the company’s business fundamentals. Manipal Health is one of India’s largest hospital chains, but analysts have noted that much of its growth potential may already be priced into the issue. As a result, expectations of significant listing gains have moderated in recent days.
